Literature DB >> 17126607

The development and validation of the Epilepsy and Learning Disabilities Quality of Life (ELDQOL) scale.

Deborah Buck1, Monica Smith, Richard Appleton, Gus A Baker, Ann Jacoby.   

Abstract

Few suitable instruments exist for use with people, especially children, with both epilepsy and learning disabilities. One such measure is the Epilepsy and Learning Disabilities Quality of Life scale (ELDQOL), which has recently undergone revision following feedback from relevant users. This article reports on the final psychometric testing phase of this scale. ELDQOL consists of 70 items covering seizure severity, seizure-related injuries, antiepileptic drug side effects, behavior, mood, physical, cognitive, and social functioning, parental concern, communication, overall quality of life, and overall health. Revalidation involved a qualitative phase, to ascertain users' opinions on the wording, coverage, and layout of the questionnaire, and a quantitative phase, to examine internal consistency, test-retest reliability, and validity. There is very good evidence of the reliability and validity of the final version of ELDQOL, making it a promising instrument for assessing quality of life in children/young adults with epilepsy and learning disabilities.

Entities:  

Mesh:

Year:  2006        PMID: 17126607     DOI: 10.1016/j.yebeh.2006.10.010

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  7 in total

1.  Training nurses in a competency framework to support adults with epilepsy and intellectual disability: the EpAID cluster RCT.

Authors:  Howard Ring; James Howlett; Mark Pennington; Christopher Smith; Marcus Redley; Caroline Murphy; Roxanne Hook; Adam Platt; Nakita Gilbert; Elizabeth Jones; Joanna Kelly; Angela Pullen; Adrian Mander; Cam Donaldson; Simon Rowe; James Wason; Fiona Irvine
Journal:  Health Technol Assess       Date:  2018-02       Impact factor: 4.014

2.  Wordless intervention for epilepsy in learning disabilities (WIELD): study protocol for a randomized controlled feasibility trial.

Authors:  Marie-Anne Durand; Bob Gates; Georgina Parkes; Asif Zia; Karin Friedli; Garry Barton; Howard Ring; Linda Oostendorp; David Wellsted
Journal:  Trials       Date:  2014-11-20       Impact factor: 2.279

3.  Wordless intervention for people with epilepsy and learning disabilities (WIELD): a randomised controlled feasibility trial.

Authors:  Silvana E Mengoni; Bob Gates; Georgina Parkes; David Wellsted; Garry Barton; Howard Ring; Mary Ellen Khoo; Deela Monji-Patel; Karin Friedli; Asif Zia; Lisa Irvine; Marie-Anne Durand
Journal:  BMJ Open       Date:  2016-11-10       Impact factor: 2.692

4.  Improving outcomes in adults with epilepsy and intellectual disability (EpAID) using a nurse-led intervention: study protocol for a cluster randomised controlled trial.

Authors:  Howard Ring; Nakita Gilbert; Roxanne Hook; Adam Platt; Christopher Smith; Fiona Irvine; Cam Donaldson; Elizabeth Jones; Joanna Kelly; Adrian Mander; Caroline Murphy; Mark Pennington; Angela Pullen; Marcus Redley; Simon Rowe; James Wason
Journal:  Trials       Date:  2016-06-24       Impact factor: 2.279

5.  Clinical services for adults with an intellectual disability and epilepsy: A comparison of management alternatives.

Authors:  Adam P Wagner; Tim J Croudace; Naomi Bateman; Mark W Pennington; Elizabeth Prince; Marcus Redley; Simon R White; Howard Ring
Journal:  PLoS One       Date:  2017-07-03       Impact factor: 3.240

6.  Epilepsy-specific patient-reported outcome measures of children's health-related quality of life: A systematic review of measurement properties.

Authors:  Holly Crudgington; Morwenna Rogers; Hannah Morris; Paul Gringras; Deb K Pal; Christopher Morris
Journal:  Epilepsia       Date:  2020-01-17       Impact factor: 5.864

7.  Safety and Tolerability of Transdermal Cannabidiol Gel in Children With Developmental and Epileptic Encephalopathies: A Nonrandomized Controlled Trial.

Authors:  Ingrid E Scheffer; Joe Hulihan; John Messenheimer; Shayma Ali; Ngaire Keenan; Jim Griesser; Donna L Gutterman; Terri Sebree; Lynette G Sadleir
Journal:  JAMA Netw Open       Date:  2021-09-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.